Preferred Name |
Mupirocin |
|
Synonyms |
|
|
Definitions |
A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C29271 |
|
CAS_Registry |
12650-69-0 |
|
Chemical_Formula |
C26H44O9 |
|
code |
C29271 |
|
Contributing_Source |
FDA |
|
definition |
A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04) |
|
FDA_UNII_Code |
D0GX863OA5 |
|
Has_Salt_Form | ||
in_subset | ||
label |
Mupirocin |
|
Legacy Concept Name |
Mupirocin |
|
Preferred_Name |
Mupirocin |
|
prefixIRI |
NCIT:C29271 |
|
prefLabel |
Mupirocin |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0085259 |
|
subClassOf |